Professional
Added to YB: 2024-10-22
Pitch date: 2024-09-30
EW [neutral]
Edwards Lifesciences Corporation
+25.73%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
Market Cap
$50.0B
Pitch Price
$66.08
Price Target
N/A
Dividend
N/A
EV/EBITDA
25.79
P/E
37.70
EV/Sales
7.97
Sector
Health Care Equipment and Supplies
Category
N/A
Show full summary:
Baron Health Care Fund Portfolio Holding: Edwards Lifesciences Corporation
EW (sold): Surgical & transcatheter heart valve maker. Q2 miss & lowered guidance due to hospital backlogs or possible competition. 2025 earnings likely lower from acquisitions & critical care biz sale. Tax loss taken while reconsidering investment thesis.
Read full article (1 min)